Insider Transactions in Q2 2024 at Teva Pharmaceutical Industries LTD (TEVA)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2024
|
Roberto Mignone |
SELL
Open market or private sale
|
Indirect |
519,000
-34.6%
|
$8,823,000
$17.03 P/Share
|
|
Jun 15
2024
|
Roberto Mignone |
BUY
Exercise of conversion of derivative security
|
Direct |
21,108
+1.31%
|
-
|
|
Jun 15
2024
|
Tal Zvi Zaks |
BUY
Exercise of conversion of derivative security
|
Direct |
21,108
+30.05%
|
-
|
|
Jun 15
2024
|
Rosemary A Crane |
BUY
Exercise of conversion of derivative security
|
Direct |
21,108
+16.92%
|
-
|
|
Jun 15
2024
|
Ronit Satchi Fainaro |
BUY
Exercise of conversion of derivative security
|
Direct |
21,108
+19.3%
|
-
|
|
Jun 15
2024
|
Perry Nisen |
BUY
Exercise of conversion of derivative security
|
Direct |
21,108
+18.07%
|
-
|
|
Jun 15
2024
|
Gerald M Lieberman |
BUY
Exercise of conversion of derivative security
|
Direct |
21,108
+16.6%
|
-
|
|
Jun 15
2024
|
Janet S. Vergis |
BUY
Exercise of conversion of derivative security
|
Direct |
21,108
+24.78%
|
-
|
|
Jun 15
2024
|
Sol J Barer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,598
+8.42%
|
-
|
|
Jun 15
2024
|
Amir Elstein |
BUY
Exercise of conversion of derivative security
|
Direct |
21,108
+1.0%
|
-
|
|
May 16
2024
|
Amir Weiss Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
12,635
-70.93%
|
$202,160
$16.65 P/Share
|
|
May 15
2024
|
Amir Weiss Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
15,500
-46.53%
|
$248,000
$16.8 P/Share
|
|
May 13
2024
|
Vikki L Conway |
SELL
Open market or private sale
|
Direct |
15,219
-100.0%
|
$243,504
$16.74 P/Share
|